DRUG · Mapped RxNorm record
eculizumab
Normalized identity: eculizumabView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Safety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
NCT00485576
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedSafety and Efficacy Study of Eculizumab in Patients With Mild Allergic Asthma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Allergic Asthmaverified · MONDO: allergic asthma
Interventions
eculizumabDRUG · verified · RxNorm: eculizumab
Sponsors & collaborators
Alexion Pharmaceuticals, Inc.lead sponsor
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00485576 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.